Your dog was diagnosed with Oral Fibrosarcoma. Third most common oral malignancy in dogs. Critical diagnostic trap: oral fibrosarcoma in large breeds (especially Golden Retrievers, 54% of cases) appears histologically low-grade but behaves aggressively (high local recurrence, metastatic potential). Predominantly maxillary location (72%). Compare 2 treatment options for dogs including Mandibulectomy / Maxillectomy, Surgery + Adjuvant Hypofractionated Radiation — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Oral Fibrosarcoma
Canine Oncology Treatment Guide
Oral Fibrosarcoma
Mesenchymal
About This Cancer
Oral fibrosarcoma is the third most common malignant tumour of the mouth in dogs, arising from fibrous connective tissue cells (fibroblasts). A critical feature of this cancer in large breed dogs, particularly Golden Retrievers, is that it presents a diagnostic trap: under the microscope the tumour cells may appear relatively benign and well-differentiated (low-grade histology), yet the tumour actually behaves very aggressively with high rates of local invasion into bone and a significant risk of distant spread. This disconnect between microscopic appearance and clinical behaviour is well-recognised in veterinary oncology and means that pathology reports can be misleadingly reassuring. The tumour most commonly develops in the upper jaw (maxilla) and is treated with aggressive surgical excision — the adequacy of surgical margins is the most important factor in determining outcome.
WHO Clinical Staging for Canine Oral Tumours (TNM)
Standard TNM staging system for canine oral tumours. Applicable to oral fibrosarcoma, melanoma, SCC, and other oral malignancies.
Prognostic Factors(2)
Minimum Workup(5 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.